|Bid||0.00 x 900|
|Ask||0.00 x 800|
|Day's Range||121.50 - 122.58|
|52 Week Range||78.49 - 123.43|
|Beta (3Y Monthly)||0.34|
|PE Ratio (TTM)||85.40|
|Earnings Date||Oct 17, 2019 - Oct 21, 2019|
|Forward Dividend & Yield||2.98 (2.43%)|
|1y Target Est||123.73|
Each day, Benzinga takes a look back at a notable market-related moment that occurred on this date. What Happened On this day 23 years ago, Gillette bought Duracell for $7 billion. Where The Market Was ...
Procter & Gamble is taking advertising to the next level by creating content with National Geographic in a six-part documentary series that seeks to draw attention to the root causes of poverty.
The Zacks Analyst Blog Highlights: Microsoft, Merck, Procter & Gamble, United Technologies and Coca-Cola
Procter & Gamble's (PG) focus on improving its product portfolio through strategic initiatives bodes well. Also, the company is on track with its cost-saving plans.
They may not be the headline-making stocks you read about on a daily basis, but these three companies have been keeping you stocked up on food and household supplies.
Consumer products giant Kimberly-Clark is beginning to enjoy a nice revival. New CEO Mike Hsu explains why in an interview with Yahoo Finance.
Procter & Gamble has opened the company’s first Smart Lab with the goal of moving consumer research projects from concept to execution within weeks.
It feels like markets have been inching toward this point for some time. The point I'm referring to is some constructive commentary regarding trade between the U.S. and China, the world's two largest economies.Source: aapsky / Shutterstock.com News hit the wires last night that representatives of the two nations will meet in Washington, D.C. next month to discuss trade issues. The news sent markets soaring today. Importantly, the S&P 500 broke past some stiff resistance today, encouraging some technical analysts to opine that this rally might have some legs to it. That would be extraordinary, considering September's dubious reputation.Adding to stocks' gains today was a bullish private payroll survey from ADP, which showed the addition of 195,000 private sector jobs in August, easily topping the 148,000 new jobs economists, on average, had expected. The Department of Labor reveals its August jobs number tomorrow before the bell, with economists on average expecting the addition of 160,000 new jobs, with unemployment holding steady at 3.7% and wages growing 3%.InvestorPlace - Stock Market News, Stock Advice & Trading Tips * 7 Stocks to Buy In a Flat Market Today, the Nasdaq Composite surged 1.75% while the S&P 500 climbed 1.31% to put the technically significant 3,100 level back in play. The Dow Jones Industrial Average gained 1.41%. In late trading, 27 of the Dow's 30 components were higher. Winners GaloreStoked by the trade news, tariff-sensitive Caterpillar (NYSE:CAT) was one of the Dow's best-performing names today, gaining more than 3%.Shares of Caterpillar "headed for the biggest gain since April as trade tensions eased, improving the sales outlook for the world's largest maker of construction and mining equipment," according to Bloomberg.Caterpillar's Thursday move wasn't surprising, but it was a pleasant surprise to see International Business Machines (NYSE:IBM) keeping pace with Caterpillar for top honors in the Dow today.IBM, a good way for conservative investors to get some tech exposure, is on a torrid pace of late, up nearly 4% this week. With today's surge, the stock reclaimed its 50-day moving average. IBM stock could reach $150 to $155 in the near-term.Industrial conglomerate United Technologies (NYSE:UTX) jumped more than 1% following some bullish analyst chatter. Cowen analyst Cai von Rumohr likes United Technologies stock and recommends buying the name right here, right now."Investors seem fixated on the [Raytheon] merger but under-appreciate major cyclical turns at Otis [and] Pratt, [United Tech's] recession resistance, and likely [second-half earnings] beats," von Rumohr said in a Wednesday research report. "With [the] separation [and] merger on track, transactional overhang should abate, offering upside to our $150 [price target]."Exxon Mobil (NYSE:XOM), a name I highlighted yesterday, also gained more than 1% today on news that the largest U.S. oil company is selling its Norwegian oil and gas assets for $4 billion. The move should help the company bolster its cash flow. Exxon's cash position is one reason some analysts remain enthusiastic about the stock. Odds And EndsWith investors flocking to riskier assets today, bond yields soared (finally), helping each of the Dow's financial services components trade noticeably higher on the day. That included Goldman Sachs (NYSE:GS).Underscoring banks' sensitivity to low interest rates, shares of Goldman jumped more than 2% despite noted bank analyst Dick Bove of Odeon Capital cutting his rating on the investment bank to "hold" from "buy." The analyst noted that GS' trimming some high level executives "suggests an unhealthy level of turmoil."The Dow offenders today were defensive names Coca-Cola (NYSE:KO), Johnson & Johnson (NYSE:JNJ) and Procter & Gamble (NYSE:PG). All fell by modest percentages. Bottom LineInvestors got significant help today on the trade front. Tomorrow is a new today and one that brings comments from Federal Reserve Chairman Jerome Powell. If the jobs number is strong and the trade talks appear viable, investors hoping for more rate cuts may want to pin those hopes on 25, not 50, basis points. As it is, some market observers believe global central banks are close to running out of tools."The U.S. is not quite there yet, but we will see as soon as next month how much closer the ECB gets to monetary debasement (we think they're still some ways away, as they haven't fully exhausted their negative interest rate path, it seems)," said BlackRock. "Ironically, the beggar-thy-neighbor implications of competitive devaluations will almost certainly incite a response from countries who may not originally even have needed to resort to currency debasement in the first place, raising the potential for full blown currency war."As of this writing, Todd Shriber does not own any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Deeply Discounted Energy Stocks to Buy * 7 Stocks to Buy In a Flat Market * 10 Stocks to Buy to Ride China's Emerging Wealth The post Dow Jones Today: Finally, Some Relief on the Trade Front appeared first on InvestorPlace.
School supplies are important for every student, but period products are often overlooked as a vital necessity to ensure girls are able to stay in class and focused on their education. This September, Always continues their #EndPeriodPoverty efforts launched in 2018 to raise awareness and take action to help keep girls in school.
AptarGroup's (ATR) partnership with PureCycle backs its vision for a circular economy, where materials and products are recycled without being reduced to waste.
Market volatility, tariff tensions with China, the inverted bond yield curve – all are coming together now and prompting recession fears. The factors are linked. The trade war with China is escalating (new tariffs on $112 billion worth of Chinese goods went into effect on September 1), increasing the chances of a more direct impact on the American consumer’s wallet and adding to recession-related worries. Nervous investors are more likely to buy and sell, adding to volatility. The lack of short-term confidence pushes up the cost of the 2-year bond, driving it above the 10-year bond. The inverted yield curve is widely seen as an early predictor of recession, occurring as much as two years before an actual downturn.So, it’s fair to say that the sky, for investors, is growing cloudy. There may be trouble on the horizon, but of what sort, it’s hard to say. It does, however, make the present the best time to buy into the classic defensive stocks. These are companies that focus on staples, in food and drink, or home health products, or low-cost family entertainment, that bring in steady return no matter the economic conditions. They offer investors strong fundamentals and reliable dividends.We’ll look at four here, all blue-chip investments, including one of Warren Buffett’s favorites, based on the TipRanks Stock Screener. Coca-Cola Company (KO)Warren Buffett loves Coke. He doesn’t hide it; he’s sat in front of Congress with a Coke in hand. And along with his love of the cola, he loves the stock. The Coca-Cola Company meets some of Buffett’s chief criteria for a long-term investment: It has an excellent reputation and one of the world’s best-known brands supporting a business that can practically run itself. As Buffett is reported to have told Bill Gates, “A ham sandwich could run Coca-Cola.”The reputation and branding are the keys. In a less facetious moment, Buffett also once said, “If you gave me $100 billion and said take away the soft drink leadership of Coca-Cola in the world, I'd give it back to you and say it can't be done.” Buffett’s confidence is built on Coke’s moat, a term Buffett uses for the protection the company gains from its long-term ability to protect its business niche and market share. In addition, Buffett appreciates Coke’s dividend. While modest, at 2.89%, it provides a steady $1.60 per share annually.Buffett is not the only fan of Coca-Cola stock. Morgan Stanley analyst Dara Mohsenian recently met with the company’s CFO and came away convinced that KO is poised for further growth. He noted three reasons why Coke’s future is bright: “Improved execution and relationships with bottler partners worldwide; a focus on smaller and higher priced goods; and new product innovation, which accounts for 25% of total revenue versus 15% just two years ago.” Mohsenian gives KO shares a price target of $60, suggesting an upside potential of 8%.Overall, KO shares hold a Moderate Buy rating from the analyst consensus, based on 6 buy and 5 hold ratings set in the last three months. Shares are selling for $55 in today’s trading, and the average price target of $57 gives the stock a potential upside of 3%. Johnson & Johnson (JNJ) Like Coke, Johnson & Johnson has an easily recognizable brand. From its ‘no more tears’ baby shampoo to Band Aids, Tylenol, and Listerine, the company’s products are widely used and perennially popular. Along with the company’s pharmaceutical line, which includes drugs to treat autoimmune conditions, cancer, hepatitis, and depression, these products give JNJ the same type of moat that defends Coca-Cola. The company shares its success through a 2.95% dividend, with a $3.80 annualized payout.Even strong defensive stocks can feel pressure, however, and JNJ has had some bed news recently. The company was named as a defendant in a Federal lawsuit brought by the State of Oklahoma, seeking damages for the epidemic of opioid addiction in the US. In a decision last month, a Federal judge JNJ liable for up to $572 million.While hardly good news, the lawsuit and verdict did not deter 5-star analyst Joanne Wuensch, of BMO Capital, from setting a buy rating on the stock. She noted the company is not required to pay anything until after the appeals process, which can easily last until 2021, and that JNJ has the cash on hand to simply pay the judgement now if it chooses. In her note, she says, “Notwithstanding the $15.2 billion in cash, equivalents and marketable securities on the second-quarter balance sheet and its AAA credit rating, J&J is not into the habit of accruing legal payments until they are probable and reasonably estimated. We remind investors that litigation is long, lengthy, and difficult to read, and while the amount is less than it could have been, we would expect an extended resolution.” She put a $157 price target JNJ shares, implying an upside of 21%.Her optimism is shared by Raymond James analyst Jayson Bedford. While declining to set a specific price target on the stock, Bedford agrees with Wuensch about the likely long-term path of the litigation. He says, “After speaking with management, we remain optimistic in the defense case for J&J when heading to the appellate courts and ultimately believe the $572M will likely be reduced.” In line with his optimism, he gives JNJ shares a firm buy rating.The analyst consensus on Johnson & Johnson is another Moderate Buy, based on an even split of 4 buys and 4 holds. In a sign of the stock’s underlying strength, the $151 average price target suggests an upside of 17% from the share price of $128. Procter & Gamble Company (PG)Since the spring of 2018, Procter & Gamble has been showing steady share price growth, regardless of the broader market conditions. In an obvious indicator of the stock’s steady growth, PG is up 32% year-to-date.Procter & Gamble has built its success on a diverse line-up of home-health and cleaning products, including Tide laundry detergent, Ivory soap, Pampers, Crest toothpaste, and Charmin toilet paper. For the most part, these are true staple products, needed in every household, and they underlie PG’s $67 billion-plus per year in revenue. The company shares those revenues with investors, through a dividend. Like the other stocks in this list, PG’s dividend offers a modest yield, at 2.46%, but offsets that with a $2.98 annualized payout and a reliable payment history.Morgan Stanley’s Dara Mohsenian, quoted above on Coca-Cola, is also bullish on PG. He gives the stock a $129 price target, and said that the company’s recently completed fiscal year gave “…greater confidence in our thesis that the company's market share gains and strong category pricing can continue to drive above-consensus topline growth. Coupled with P&G's outsized gross margin expansion, we expect higher EPS growth than peers.” Mohsenian’s price target suggests 5% upside to the stock.PG’s recent gains have pushed the stock right up to its $122 average target. The share price is now $121, leaving room for just a 1% upside. This is reflected in the Moderate Buy analyst consensus, based on 4 buys and 5 holds from the past three months. Walt Disney Company (DIS)The House of Mouse is a perennial strong performer, based on the solid foundation of the famed Disney Vault, a near-century’s worth of animated and live action family films, and the universal brand of Mickey Mouse. Disney has defended both its reputation and its profitability over the years, partly by producing consistently high-quality films, partly by making smart acquisitions, and partly by adapting to changes in the movie industry. The company now owns the Star Wars and Marvel franchises, along with a cruise line, consumer products like Disney Princesses, and ESPN.This array of entertainment business is enormously lucrative, and in its last fiscal year Disney recorded almost $60 billion in revenues and over $12 billion in net income. Shareholders benefit directly from the 1.29% dividend yield, which gives them a payout of $1.76 per share annually. The company is using its income and cash flow to continue its history of adaptation to changing conditions; Disney will launch a streaming service later this year, competing directly with giants like Netflix (NFLX) and Apple (AAPL) in the online TV-on-demand space. The Disney Vault – a giant well of fully-owned content of proven popularity – will undoubtedly give the Mouse a leg up in that competition.5-star analyst Ivan Feinseth of Tigress Financial reviewed Disney last week and affirmed his upbeat outlook on the stock. He believes a recent pullback in share price offers investors a point of entry, and writes, “[We see] the company's continued accelerating business performance from its strong studio results and expect the ramp of its DTC streaming service to generate increasing return on capital. This stock is in our Research Focus List and also our Focus Opportunity Portfolio. Management is still investing significant cash in new growth initiatives and strategic acquisitions.”Of the four stocks in this list, Disney is the one with a Strong Buy from the analyst consensus. The stock has received 11 buys and 3 holds over the past three months, a clear sign of investor confidence. The average price target of $156 suggests an upside potential of 14% from the share price of $136.Visit TipRanks’ Analysts Top Stocks page to find out which companies have the attention of Wall Street’s best analysts.
Procter & Gamble Co. has sold two home care brands to Prestige Value Brands, a Cincinnati firm formed to acquire the rights in the Americas to P&G’s Joy Hand Dish Retail, Joy Hand Dish PGP and Cream Suds PGP businesses. Beverly Grant, chief commercial officer of Prestige Value Brands, is a former P&G executive.
Procter & Gamble Co. partnered with National Geographic on the latest element of an advertising campaign that aims to keep girls in school as they enter puberty.
The CoMade initiative led by a former Procter & Gamble Co. executive has opened a tool library at the former Kroger store in Walnut Hills from which residents can borrow everything from hammers to power tools such as tile saws to improve their homes and the community.
Aurora Cannabis (NYSE:ACB) is coming off a brutal August, the latest in a long line of rough months for the Canadian cannabis company. With each month of struggles, the shares become a little more tempting.Source: Shutterstock With an annual cannabis output that now exceeds 625,000 kilograms, it's easy to see why some investors may find Aurora stock attractive. The company offers scale in an often fragmented market. It's one of the world's largest cannabis producers and some of its core competencies include industry-leading output and logistical capabilities.Last month, the company released preliminary fiscal fourth-quarter results, including a forecast of sales of $100 million CAD to $107 million CAD. That's good for a roughly five-fold increase from the year-earlier period and 60% quarter-over-quarter growth. Those headlines temporarily bought ACB stock some goodwill among investors. However, as Aurora stock has often shown, making the good times last is easier said than done.InvestorPlace - Stock Market News, Stock Advice & Trading TipsThe company's official quarterly earnings report is due out Sept. 15 and that should be a catalyst, in one way or another, for Aurora Cannabis stock. Management also upped its production outlook to 25,000 kilograms to 30,000 kilograms, above a previous forecast calling for 25,000 kilograms at the high end.Cowen analyst Vivien Azer noted that these preliminary results imply stronger-than-expected yields, which could help the company approach a cost per gram of less than $1 CAD, or 75 U.S. cents. Sourcing Growth for Aurora CannabisIntegral to the long-term thesis for Aurora stock is management's ability to find growth channels outside of Canada and the medicinal marijuana market. Those are viable growth opportunities, but they are largely baked into Aurora stock. By some forecasts, medicinal marijuana will see some contraction in the coming years.Morningstar's Kristoffer Inton said that he believes the medical market will shrink as recreational use is legalized. He also forecasts 20% average annual growth for the next decade, thanks to "black-market" consumers moving towards legal use. * 7 Best Tech Stocks to Buy Right Now That's a perfect segue into talking about the U.S. Cannabis companies and investors are betting that increased U.S. legalization will bring recreational use out of the shadows. While some states have signed off on it, cannabis for medical and recreational purposes is illegal at the federal level in the U.S.Aurora Cannabis is eyeing the U.S. market in its own way, and acknowledges that a footprint south of it home market "is nonnegotiable." There are plenty of other reasons why ACB stock could get a jolt. The company just needs U.S. policymakers' attitude toward cannabis to loosen up."Not only is the U.S. a larger opportunity, but it has a better economic model," GMP Securities analyst Rob Fagan told Barron's. "In most states, you're allowed to go direct to your customer -- from production right up to retail -- cashing in on more of the value chain. There are also fewer restrictions on product forms and advertising than in Canada." Finding a Partner for ACB StockUnlike some of its rivals, Aurora Cannabis is currently without partners from the tobacco or beverage industries, although the company has admitted Coca-Cola (NYSE:KO) would make for an appealing partner.This goes back to Aurora's relationship with activist investor Nelson Peltz. Peltz has famously (and successfully) pushed for change at companies such as Procter & Gamble (NYSE:PG), Mondelez (NASDAQ:MDLZ) and Wendy's (NASDAQ:WEN). However, the relationship with Peltz is something that is also baked into Aurora Cannabis stock. Investors are now demanding something substantive to come of his involvement.Inton said that Aurora Cannabis is limited in its potential to benefit from new partnerships. This is because of its lack of exposure in the U.S. market.For ACB stock, the writing is on the wall. The company must make a credible foray into the U.S. and execute on that endeavor, or risk generating dissatisfaction.The U.S. market remains an "X factor" for Canadian cannabis companies. But, the good news is that Aurora Cannabis stock is well below a credible fair value estimate of $9-$10.Todd Shriber does not own any of the aforementioned securities. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Best Tech Stocks to Buy Right Now * 10 Mid-Cap Stocks to Buy * 8 Precious Metals Stocks to Mine For The post Aurora Cannabis Needs to Keep its Finger on the Marijuana Pulse appeared first on InvestorPlace.